{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:45:08Z","timestamp":1774449908302,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2019,3]]},"abstract":"\n Significance Statement<\/jats:title>\n Patients with ESRD experience a substantially increased incidence of cancer, but few studies have examined patterns of cancer mortality among such patients. This population-based cohort study of Australian patients who initiated dialysis or received a kidney transplant from 1980 to 2014 found that the risk of cancer-related death among 52,936 patients on dialysis and 16,820 kidney transplant recipients was 2.5 times higher than that of age- and sex-matched controls in the general population. For patients on dialysis, increased cancer mortality is primarily from cancers that caused ESRD; among transplant recipients, the increase is largely due to de novo<\/jats:italic> cancers. Additional efforts are required to clarify factors and mechanisms involved in increased cancer risk and to improve early detection and management of cancer in this population.<\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Patients with ESRD have a substantially increased cancer risk, but few studies have examined the patterns of cancer mortality along a patient's journey from dialysis to transplantation.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We identified all Australian patients on dialysis and patients with transplants from 1980 to 2014 from the Australia and New Zealand Dialysis and Transplant Registry. Using standardized mortality ratios (SMRs), we compared cancer mortality among patients on dialysis and patients with transplants versus the general population (overall and by age, sex, year, and site); we also performed a subgroup analysis excluding patients with preexisting cancers.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n We followed 52,936 patients on dialysis and 16,820 transplant recipients for 170,055 and 128,352 patient-years, respectively. There were 2739 cancer deaths among patients on dialysis and 923 cancer deaths among transplant recipients. Overall, cancer SMRs were 2.6 for patients on dialysis and 2.7 for transplant recipients. For patients on dialysis, SMRs were highest for multiple myeloma (30.5), testicular cancer (17.0), and kidney cancer (12.5); for transplant recipients, SMRs were highest for non-Hodgkin lymphoma (10.7), kidney cancer (7.8), and melanoma (5.8). Some 61.0% of patients on dialysis and 9.6% of transplant recipients who experienced cancer death had preexisting cancer. The SMRs for de novo<\/jats:italic> cancer was 1.2 for patients on dialysis and 2.6 for transplant recipients.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Patients on dialysis and transplant recipients experienced >2.5-fold increased risk of cancer death compared with the general population. This increased risk was largely driven by preexisting cancers in patients on dialysis and de novo<\/jats:italic> cancers in patients with transplants.<\/jats:p>\n <\/jats:sec>","DOI":"10.1681\/asn.2018090906","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T19:35:15Z","timestamp":1550172915000},"page":"471-480","source":"Crossref","is-referenced-by-count":116,"title":["Overall and Site-Specific Cancer Mortality in Patients on Dialysis and after Kidney Transplant"],"prefix":"10.1681","volume":"30","author":[{"given":"Eric H.","family":"Au","sequence":"first","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, Australia;"},{"name":"Centre for Kidney Research, The Children\u2019s Hospital at Westmead, Sydney, Australia;"},{"name":"Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia;"}]},{"given":"Jeremy R.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia;"}]},{"given":"Jonathan C.","family":"Craig","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, Australia;"}]},{"given":"Wai H.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia;"}]},{"given":"Armando","family":"Teixeira-Pinto","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, Australia;"},{"name":"Centre for Kidney Research, The Children\u2019s Hospital at Westmead, Sydney, Australia;"}]},{"given":"Shahid","family":"Ullah","sequence":"additional","affiliation":[{"name":"Australia and New Zealand Dialysis and Transplant Registry, South Australian Health and Medical Research Institute, Adelaide, Australia; and"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide, Australia"}]},{"given":"Stephen","family":"McDonald","sequence":"additional","affiliation":[{"name":"Australia and New Zealand Dialysis and Transplant Registry, South Australian Health and Medical Research Institute, Adelaide, Australia; and"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide, Australia"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Sydney, Sydney, Australia;"},{"name":"Centre for Kidney Research, The Children\u2019s Hospital at Westmead, Sydney, Australia;"},{"name":"Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia;"}]}],"member":"276","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: An international collaborative study.","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1093\/ndt\/gfp331","article-title":"The pattern of excess cancer in dialysis and transplantation.","volume":"24","author":"Stewart","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation.","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients.","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: A UK Registry audit.","volume":"10","author":"Collett","year":"2010","journal-title":"Am J Transplant"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","article-title":"Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.","volume":"65","author":"Butler","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/TP.0b013e3181caeead","article-title":"Reduction in cardiovascular death after kidney transplantation.","volume":"89","author":"Pilmore","year":"2010","journal-title":"Transplantation"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","article-title":"Cancer mortality among recipients of solid-organ transplantation in ontario, canada.","volume":"2","author":"Acuna","year":"2016","journal-title":"JAMA Oncol"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/ndt\/gfv007","article-title":"Mortality from infections and malignancies in patients treated with renal replacement therapy: Data from the ERA-EDTA registry.","volume":"30","author":"Vogelzang","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1440-1797.2010.01297.x","article-title":"Validity of registry data: Agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).","volume":"15","author":"Webster","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"B14-20230819","article-title":"Comparison of cause of death between anzdata and the australian national death index [published online ahead of print March 1, 2018].","author":"Sypek","journal-title":"Nephrology (Carlton)"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis.","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients.","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1681\/ASN.2015040373","article-title":"Variation in cancer incidence among patients with ESRD during kidney function and nonfunction intervals.","volume":"27","author":"Yanik","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/j.1600-6143.2012.04209.x","article-title":"Malignancies after kidney transplantation: Hong Kong renal registry.","volume":"12","author":"Cheung","year":"2012","journal-title":"Am J Transplant"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ki.2013.458","article-title":"Malignancy-related mortality following kidney transplantation is common.","volume":"85","author":"Farrugia","year":"2014","journal-title":"Kidney Int"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2009.02728.x","article-title":"Cancer mortality in kidney transplantation.","volume":"9","author":"Kiberd","year":"2009","journal-title":"Am J Transplant"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TP.0b013e3182637078","article-title":"Clinical practice guidelines on wait-listing for kidney transplantation: Consistent and equitable?","volume":"94","author":"Batabyal","year":"2012","journal-title":"Transplantation"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis.","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"B24-20230819","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfx356","article-title":"The incidence and predictors of post-transplant lymphoproliferative disease (PTLD) after kidney transplantation during adulthood and childhood.","volume":"33","author":"Francis","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"15088","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders.","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B26-20230819","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/01.TP.0000120181.89206.54","article-title":"Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation.","volume":"77","author":"Guba","year":"2004","journal-title":"Transplantation"},{"key":"B27-20230819","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint inhibitors in kidney transplant Recipients and the potential risk of rejection.","volume":"16","author":"Alhamad","year":"2016","journal-title":"Am J Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001751-201903000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T17:59:04Z","timestamp":1692467944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001751-201903000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2018090906","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]}}}